Damora Therapeutics Inc (GLTO) Live Share Price, Invest From India

Damora Therapeutics Inc Stock Performance

as on March 10, 2026 at 6:59 am IST

Day's Low
Day's High
$26.43
Day's Price Range
$30.39
$28.29
6.57%
Downside
7.42%
Upside
52 Week's Low
52 Week's High
$2.45
52-Week Price Range
$38.33
$28.29
91.34%
Downside
35.47%
Upside

Damora Therapeutics Inc share price movements today

Previous Close: $28.91
Open: $28.85
Volume: 273.9K
Day's Low - High: $26.43 - $30.39
52 Week Low - High: $2.45 - $38.33

Damora Therapeutics Inc Historical Returns

1 Month Return: 0 %
3 Month Return: 0 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Damora Therapeutics Inc Stock Fundamentals & Key Indicators

Check Damora Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

0.00%

Damora Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Damora Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Damora Therapeutics Inc	BUY	$-	NA	NA	0.00%	NA
Alnylam Pharmaceuticals Inc	BUY	$39.5B	114.85%	74.09	12.55%	NA
Vertex Pharmaceuticals Inc	BUY	$111.0B	114.72%	25.98	35.51%	NA
BeiGene, Ltd.	NA	$31.1B	NA	67.88	8.94%	NA
Regeneron Pharmaceuticals Inc	BUY	$65.8B	23.7%	15.34	29.65%	0.5599999999999999%

Analyst Recommendation on Damora Therapeutics Inc Stock

Based on 8 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 8 analysts, 75% of analysts recommend a 'BUY' rating for Damora Therapeutics Inc. Average target price of $32

Damora Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Damora Therapeutics Inc.

What analysts predicted

11.59%UPSIDE

Target Price

$32

Current Price

$28.29

Analyzed by

8 Analysts

Target

$32.00

Damora Therapeutics Inc target price $32, a slight upside of 11.59% compared to current price of $28.29. According to 8 analysts rating.

Damora Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	1	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	-	0	-	0
Operating Income	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-8	-6	-5	-5	-3	-6	-2	-3	-3	-200
Net Profit Margin	0.00%	-538.69%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Damora Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-	-
Gross Profit	-	0	0	0	0	0	-4	-174
Operating Income	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-
Income Before Tax	-	-	-	-	-	-	-	-
Income Tax Expense	-	-	-	-	-	-	-	-
Net Income	-15	-38	-34	-51	-61	-38	-21	-209
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Global Institutional Holdings in Damora Therapeutics Inc

Funds	Holdings
Vanguard Group Inc	0.03%
Squarepoint Ops LLC	0%
UBS Group AG	0%
Connective Capital Management LLC	0%
Jain Global LLC	0.2%

See all

Damora Therapeutics Inc News & Key Events

Insights on Damora Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, GLTO has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 6 months, GLTO stock has moved up by 870.1%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 107.6%

About Damora Therapeutics Inc

Galecto, Inc. is a clinical-stage biotechnology company focused on the development of novel treatments for cancer and liver diseases. The Company’s pipeline consists of small molecule drug candidates that target cancer and fibrosis signaling pathways, including a preclinical dual inhibitor of ENL-YEATS and FLT3 (GB3226) for multiple genetic subsets of AML; an orally active galectin-3 inhibitor (GB1211) in combination with a checkpoint inhibitor for various oncology indications and (an orally active galectin-3 inhibitor (GB1211) for the treatment of liver cirrhosis. It is developing GB3226, a preclinical small molecule dual inhibitor of ENL-YEATS and FLT3 for multiple molecularly defined subsets of acute myeloid leukemia (AML). The Company’s pipeline is GB1211, its oral small molecule galectin-3 inhibitor candidate, which is in development for the treatment of non-small cell lung cancer (NSCLC), melanoma, head and neck squamous cell carcinoma (HNSCC), and decompensated cirrhosis.

Organisation	Damora Therapeutics Inc
E-voting on shares	Click here to vote

FAQs

What is Damora Therapeutics Inc share price today?

Damora Therapeutics Inc share price today is $28.29 as on March 10, 2026 at 1:29 am IST at the close of the market. Damora Therapeutics Inc share today touched a day high of $30.39 and a low of $26.43.

What is the 52 week high and 52 week low for Damora Therapeutics Inc share?

Damora Therapeutics Inc share touched a 52 week high of $38.33 on December 26, 2025 and a 52 week low of $2.45 on September 9, 2025. Damora Therapeutics Inc stock price today i.e. March 10, 2026 at 1:29 am IST is closed at $28.29,which is 26.18% down from its 52 week high and 1054.69% up from its 52 week low.

How to invest in Damora Therapeutics Inc Stock (GLTO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Damora Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Damora Therapeutics Inc Shares that will get you 0.0530 shares as per Damora Therapeutics Inc share price of $28.29 per share as on March 10, 2026 at 1:29 am IST.

What is the minimum amount required to buy Damora Therapeutics Inc Stock (GLTO) from India?

Indian investors can start investing in Damora Therapeutics Inc (GLTO) shares with as little as ₹94.99 or $1 (as of May 31, 2026 at 10:10 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.90 in Damora Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on May 31, 2026 at 10:10 pm IST). Based on Damora Therapeutics Inc share’s latest price of $28.29 as on March 10, 2026 at 1:29 am IST, you will get 0.3535 shares of Damora Therapeutics Inc. Learn more about fractional shares .